Osteoarthritis Of Knee Clinical Trial
Official title:
Feasibility of Outpatient Total Knee Arthroplasty
This proposal outlines the investigators plan to develop, evaluate and implement an accelerated in hospital and community rehabilitation following total knee arthroplasty (TKA) leading to outpatient TKA. The benefits of applying current concepts of improved postoperative analgesia and less invasive surgical technique are expected to improve objective parameters of knee function, increase patients satisfaction, while reducing health care resources requirements as compared with standard rehabilitation. The innovation of combining best practices from orthopaedic sports medicine, Anesthesia, Physiotherapy and Knee reconstruction are expected to realize this goal.
Consecutive patients presenting for elective TKA at the General (Dr. Dervin) will be
approached for enrollment.
Dr Dervin will present the study to their patients who are appropriate for the study when
first confirmed for joint replacement after clinic assessment. If the patient has indicated
that they are interested, the surgeon will inform the research coordinator who will then
continue the consenting process. The research coordinator will confirm patient's eligibility
to ensure that all inclusion and no exclusion criteria are met. The study will be explained
in detail to qualify patients and they will be provided with a copy of the consent form. The
consent form will also provide a clause of confidentiality informing patient privacy. All
questions will be answered. Patients may also talk to the investigators with any additional
questions.
Patients will be advised preoperatively about an accelerated path while in hospital that will
share many attributes of the standard TOH care map,but with several additions, chosen to help
reduce pain and hemarthrosis, both felt to be the major impediments to faster recuperation.
1. Surgery will be performed with a muscle sparing subvastus approach, chosen because of
evidenced decreased pain.
2. Tranexamic acid ( 10 mg/kg) intravenously will be administered to further reduce blood
loss at time of tourniquet deflation.
3. The "Game Ready" cold - compression device will be used post operatively to help reduce
pain and minimize swelling.
.
Timeline:
Outcome data collection is expected to be completed by July 1, 2018 to allow for a minimum 6
month follow up.
Outcomes (Metrics):
The outcome measures are provided and are summarized here.
1. Length of stay: We will measure LOS for these patients as compared to a cohort that is
comparable in demographics who are being treated concurrently on the service
2. Analgesic use in hospital and at home (where pt will maintain a 28 day pain diary to
record analgesics taken and quality of life recovery questions) to be captured with
special interest to any opioid sparing effect
3. Physiotherapy will measure the Physical parameters such as range of motion and
quadriceps strength during stay and at discharge, 2 weeks , and 1 , 2 and 3 months
4. Patient satisfaction questionnaire outcome: after 6 months to evaluate
5. Health care resource requirement
1. Physiotherapy visits
2. Use of mobility aids duration
6. Time to return to work where applicable
Benefits to patient The benefits to the patient will be substantial by improving the pace of
recovery with less physical burden and quicker achievement of goals and resumption of normal
activity.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03274713 -
Efficacy of Electro-acupuncture Versus Manual Acupuncture on Knee Osteoarthritis
|
N/A | |
Completed |
NCT04535596 -
Blood Flow Restriction Exercises and Conservative Exercises in Knee Osteoarthritis
|
N/A | |
Completed |
NCT03918291 -
Whole-body Vibration Training on Functional Performance of the Elderly With Knee Osteoarthritis
|
N/A | |
Recruiting |
NCT06263517 -
Clinical Trial to Assess Efficacy, Tolerability of Rising Doses of Clodronate in Painful Knee Osteoarthritis Patients
|
Phase 2/Phase 3 | |
Completed |
NCT01453738 -
Allogeneic Mesenchymal Stem Cells in Osteoarthritis
|
Phase 2 | |
Active, not recruiting |
NCT01027819 -
Comparison of Outcomes in Mobile and Fixed-bearing Total Knee Arthroplasty
|
Phase 4 | |
Active, not recruiting |
NCT00261066 -
Outcome Following Orthopaedic Surgery
|
||
Completed |
NCT03484910 -
Biofeedback With Cycling Exercise in OA Knee Patients
|
N/A | |
Recruiting |
NCT03884374 -
Pain Relief for OsteoArthritis Through Combined Treatment (PROACT)
|
N/A | |
Completed |
NCT03492320 -
Progression of Health Related Quality of Life of Patients Waiting for Total Knee Arthroplasty
|
||
Completed |
NCT01449552 -
Temporary Clamping of Drains Combined With Tranexamic Acid Reduce Blood Loss After TKA: A Prospective RCT
|
N/A | |
Completed |
NCT06254976 -
Serum Nesfatin-1 and Human Cartilage Glycoprotein-39 Levels in Knee Osteoarthritis
|
N/A | |
Completed |
NCT03428893 -
Mobile Technology to Support Physical Therapy Exercise
|
N/A | |
Completed |
NCT05081921 -
Clinical Trial to Evaluate Safety and Efficacy of MesoCellA-Ortho Tissue-Engineered Advanced Therapy Product in Patients With Osteoarthrosis and Civilisation Diseases
|
Phase 1/Phase 2 | |
Completed |
NCT02850068 -
Geniculate Artery Embolization for the Treatment of Knee Pain
|
N/A | |
Active, not recruiting |
NCT03110172 -
Short-term Efficacy of Antidepressant in Patients Underwent TKA
|
Phase 1/Phase 2 | |
Enrolling by invitation |
NCT02623660 -
Microcurrent Stimulation Reduces Post-Operative Swelling and Healing Time Following Knee Replacement Surgery
|
N/A | |
Completed |
NCT02579174 -
Total Knee Replacement Component Alignment Using Manual Versus Custom Instrumentation
|
N/A | |
Completed |
NCT00790985 -
Efficacy of Flavocoxid 500 mg Compared With Naproxen 500 mg in Subjects With Moderate-severe Osteoarthritis of the Knee
|
N/A | |
Recruiting |
NCT02722811 -
Efficacy of Subcutaneous Injection of Etanercept for Moderate and Severe Knee Osteoarthritis
|
N/A |